A PYMNTS Company

China

Observations on Anti-Monopoly Developments in China’s Pharmaceutical Industry and Suggestions for Compliance
 |  Oct 7, 2024

By Shujun Liu, Lanxue Zhao, Na Li & Xiaoyu Liu1   Ever since the implementation of the People’s Republic of China’s (“PRC”) Anti-Monopoly Law (the “AML”) in 2008, the pharmaceutical…

Exploring the Evolution and Future of China’s Anti-Monopoly Law with Prof. Huang Yong
 |  Jul 31, 2024

 To celebrate the 16th anniversary of China’s Anti-Monopoly Law (AML), which took effect in August 2008, Dr. Elizabeth Wang, an Economist at Compass Lexecon, interviewed Professor Huang Yong, a…

China Releases Consultation Draft for Horizontal Merger Review Guidelines
 |  Jul 21, 2024

By Michael Han, Bivio Yu & Arthur Wong1   On June 17, 2024, China’s State Administration for Market Regulation (“SAMR”) released the Guidelines for the Review of Horizontal Mergers (“Consultation…

Yanyan Yang on China’s Merger Control
 |  Apr 22, 2024

 In this CPI Interview series, Sophie Yang, an economist with Compass Lexecon, interviewed Yanyan Yang of Latham & Watkins, a renowned multinational law firm specializing in antitrust and competition…

Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
 |  Apr 16, 2024

The revised Antimonopoly Law, as amended in June 2022, added a new system of reviewing concentrations that do not meet the standard of notification, which is a necessary supplementary rule…

China’s Review of Semiconductor Transactions
 |  Apr 16, 2024

Since the start of U.S.-China trade war in 2018, semiconductor companies found themselves in the center of crossfire in this smokeless war. As the U.S. government attempts to restrict China’s…

Key Challenges and Tips for Merger Control Filing in China for Listed Companies
 |  Apr 16, 2024

Given the characteristics of listed companies and special legal requirements for listed companies under the PRC merger control laws and regulations, there are special challenges and compliance risks concerning the…

Key Point Review: China SPC Antitrust Judgments in 2023
 |  Apr 16, 2024

Each year, the Intellectual Property Court of the PRC Supreme People’s Court published a summary of key points of its antitrust case judgments concluded in the prior year. On February…

The Interplay Between Antitrust and Private Intellectual Property Litigation in China: Patent Law and Beyond
 |  Apr 16, 2024

The interplay between antitrust and IP private litigations in China, as exemplified by recent legislations and cases, underscores the evolving landscape of IP rights enforcement within antitrust frameworks. Specifically, the…

China’s Regulation on Resale Price Maintenance: The Necessity and Path for the Implementation of the “Safe Harbor” and “Effects-Based Defense” Mechanisms
 |  Apr 16, 2024

The regulation of resale price maintenance (RPM) stands as a notably contentious issue within antitrust law. The 2022 revision of China’s Anti-monopoly Law introduced the concepts of “Safe Harbor” and…

Patent Valuation in China SEP Cases
 |  Apr 16, 2024

A decade has passed since the Guangdong High Court upheld the first Chinese telecom standard essential patents judgment in 2013.  Since then, a number of landmark judgments were handed down…

Roger Zhang on Recent Regulatory Developments
 |  Apr 11, 2024

 In an interview conducted by Dr. Yujie Qian, a Senior Economist with Compass Lexecon, Dr. Roger Zhang, Vice President for Public Affairs at Tencent, discussed the recent regulatory developments…

Loading...